Literature DB >> 30355465

Radiotherapy for newly diagnosed oligometastatic prostate cancer.

Luca Boeri1, Vidit Sharma2, R Jeffrey Karnes3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30355465     DOI： 10.1016/S0140-6736(18)32598-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer.

Authors:  Brandon S Imber; Melissa Varghese; Debra A Goldman; Zhigang Zhang; Richard Gewanter; Ariel E Marciscano; Borys Mychalczak; Daniel Gorovets; Marisa Kollmeier; Sean M McBride; Michael J Zelefsky
Journal:  Adv Radiat Oncol       Date:  2020-06-28

2.  Comparative Efficacy of Combined Radiotherapy, Systemic Therapy, and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-Analysis and Systematic Review.

Authors:  Yuhan Wang; Huiming Gui; Juan Wang; Junqiang Tian; Hanzhang Wang; Chaozhao Liang; Zongyao Hao; Ronald Rodriguez; Zhiping Wang
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.